Treatment of advanced gastrointestinal cancer with genetically modified autologous mesenchymal stem cells: Results from the phase 1/2 TREAT-ME-1 trial.
von Einem JC, Guenther C, Volk HD, Grütz G, Hirsch D, Salat C, Stoetzer O, Nelson PJ, Michl M, Modest DP, Holch JW, Angele M, Bruns C, Niess H, Heinemann V.
von Einem JC, et al. Among authors: niess h.
Int J Cancer. 2019 Sep 15;145(6):1538-1546. doi: 10.1002/ijc.32230. Epub 2019 Mar 13.
Int J Cancer. 2019.
PMID: 30801698
Free article.
Clinical Trial.